Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
This report contains market size and forecasts of Nonsteroidal Anti-inflammatory APIs in global, including the following market information:
Global Nonsteroidal Anti-inflammatory APIs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nonsteroidal Anti-inflammatory APIs Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Nonsteroidal Anti-inflammatory APIs companies in 2021 (%)
The global Nonsteroidal Anti-inflammatory APIs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aspirin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nonsteroidal Anti-inflammatory APIs include Mallinckrodt Pharmaceuticals, IOL, Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Xinhua Pharmaceutical, Granules India Limited and Changshu Huagang Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nonsteroidal Anti-inflammatory APIs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonsteroidal Anti-inflammatory APIs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nonsteroidal Anti-inflammatory APIs Market Segment Percentages, by Type, 2021 (%)
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxapcin
Other
Global Nonsteroidal Anti-inflammatory APIs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nonsteroidal Anti-inflammatory APIs Market Segment Percentages, by Application, 2021 (%)
Adult
Child
Global Nonsteroidal Anti-inflammatory APIs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nonsteroidal Anti-inflammatory APIs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nonsteroidal Anti-inflammatory APIs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nonsteroidal Anti-inflammatory APIs revenues share in global market, 2021 (%)
Key companies Nonsteroidal Anti-inflammatory APIs sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Nonsteroidal Anti-inflammatory APIs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mallinckrodt Pharmaceuticals
IOL
Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Xinhua Pharmaceutical
Granules India Limited
Changshu Huagang Pharmaceutical
Hebei Jiheng Group
ZHEJIANG KANGLE PHARMACEUTICAL
Hebei Jingye Medical Technology
Hunan Zhongnan Pharmaceutical